MIP Technologies and FeF Chemicals sign Research and Development Agreement
25-Jan-2005 -
MIP Technologies AB, a developer of
molecular molecularly imprinted polymers for separations and drug
discovery, announced that it has signed a research and development
agreement with FeF Chemicals, a subsidiary of Novo Nordisk. During this
program of work, MIP Technologies will develop for FeF a ...
diabetes
Novo Nordisk
polymers